ITI Selling And Marketing Expenses vs Research Development Analysis

ITI Stock

286.63 9.04 3.06%

ITI financial indicator trend analysis is infinitely more than just investigating ITI Limited recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ITI Limited is a good investment. Please check the relationship between ITI Selling And Marketing Expenses and its Research Development accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ITI Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ITI Limited Selling And Marketing Expenses account and Research Development. At this time, the significance of the direction appears to have almost no relationship.

The correlation between ITI's Selling And Marketing Expenses and Research Development is 0.19. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of ITI Limited, assuming nothing else is changed. The correlation between historical values of ITI's Selling And Marketing Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of ITI Limited are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling And Marketing Expenses i.e., ITI's Selling And Marketing Expenses and Research Development go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Selling And Marketing Expenses

Research Development

Most indicators from ITI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ITI Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ITI Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Issuance Of Capital Stock is expected to grow to about 925.5 M, whereas Selling General Administrative is forecasted to decline to about 384.6 M.

ITI fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Retained Earnings	Short Term Debt	Current Deferred Revenue	Other Liab
Total Assets		0.59	0.64	0.71	0.69	0.65	0.67	-0.36	-0.49	0.08	0.06	0.49	0.7	0.48	0.57	0.11	0.52	0.1	0.04	0.83	0.87	0.68	0.55	0.66	0.78	-0.35
Short Long Term Debt Total	0.59		0.18	0.33	0.64	0.71	0.98	-0.68	0.01	-0.22	-0.2	0.58	0.32	0.55	0.54	0.16	0.71	-0.07	0.14	0.41	0.66	0.61	0.11	0.72	0.3	-0.25
Other Current Liab	0.64	0.18		0.45	0.49	0.36	0.25	-0.07	-0.42	0.27	0.16	-0.25	0.47	0.2	-0.14	0.08	0.24	0.12	-0.15	0.52	0.47	0.26	0.4	0.13	0.54	-0.45
Total Current Liabilities	0.71	0.33	0.45		0.22	0.54	0.39	0.09	-0.36	-0.3	-0.2	0.47	0.85	0.59	0.47	-0.15	-0.09	0.17	-0.08	0.87	0.82	0.66	0.29	0.78	0.53	-0.4
Total Stockholder Equity	0.69	0.64	0.49	0.22		0.73	0.73	-0.62	-0.55	0.23	0.11	0.32	0.52	0.31	0.45	0.13	0.84	-0.13	-0.05	0.29	0.55	0.53	0.63	0.26	0.57	-0.44
Property Plant And Equipment Net	0.65	0.71	0.36	0.54	0.73		0.76	-0.41	-0.39	-0.24	-0.35	0.38	0.61	0.7	0.44	0.23	0.47	0.14	0.02	0.55	0.79	0.82	0.26	0.65	0.42	-0.61
Net Debt	0.67	0.98	0.25	0.39	0.73	0.76		-0.68	-0.16	-0.16	-0.18	0.6	0.42	0.55	0.59	0.14	0.75	-0.06	0.05	0.45	0.71	0.65	0.23	0.71	0.41	-0.32
Accounts Payable	-0.36	-0.68	-0.07	0.09	-0.62	-0.41	-0.68		0.1	-0.22	-0.16	-0.48	-0.08	-0.43	-0.53	-0.52	-0.85	-0.08	-0.03	-0.16	-0.28	-0.15	-0.05	-0.21	-0.4	0.03
Cash	-0.49	0.01	-0.42	-0.36	-0.55	-0.39	-0.16	0.1		-0.3	-0.1	-0.15	-0.57	-0.14	-0.3	0.06	-0.28	-0.1	0.55	-0.31	-0.33	-0.22	-0.63	-0.02	-0.64	0.39
Non Current Assets Total	0.08	-0.22	0.27	-0.3	0.23	-0.24	-0.16	-0.22	-0.3		0.75	-0.11	-0.15	-0.21	-0.1	0.29	0.37	0.32	-0.12	-0.08	-0.39	-0.47	0.2	-0.51	0.49	0.26
Non Currrent Assets Other	0.06	-0.2	0.16	-0.2	0.11	-0.35	-0.18	-0.16	-0.1	0.75		-0.04	-0.13	-0.08	0.01	0.28	0.27	0.24	0.08	-0.01	-0.29	-0.48	0.04	-0.36	0.32	0.3
Cash And Short Term Investments	0.49	0.58	-0.25	0.47	0.32	0.38	0.6	-0.48	-0.15	-0.11	-0.04		0.47	0.44	0.93	0.0	0.41	-0.04	0.06	0.46	0.51	0.41	0.22	0.64	0.48	0.11
Net Receivables	0.7	0.32	0.47	0.85	0.52	0.61	0.42	-0.08	-0.57	-0.15	-0.13	0.47		0.43	0.57	-0.29	0.12	-0.07	-0.25	0.63	0.73	0.64	0.63	0.56	0.56	-0.49
Common Stock Shares Outstanding	0.48	0.55	0.2	0.59	0.31	0.7	0.55	-0.43	-0.14	-0.21	-0.08	0.44	0.43		0.44	0.58	0.24	0.52	0.19	0.72	0.68	0.53	-0.27	0.71	0.41	-0.33
Short Term Investments	0.57	0.54	-0.14	0.47	0.45	0.44	0.59	-0.53	-0.3	-0.1	0.01	0.93	0.57	0.44		0.03	0.46	0.0	-0.09	0.48	0.58	0.48	0.35	0.6	0.51	0.04
Non Current Liabilities Total	0.11	0.16	0.08	-0.15	0.13	0.23	0.14	-0.52	0.06	0.29	0.28	0.0	-0.29	0.58	0.03		0.33	0.67	0.32	0.29	0.09	-0.07	-0.52	0.04	0.3	0.11
Inventory	0.52	0.71	0.24	-0.09	0.84	0.47	0.75	-0.85	-0.28	0.37	0.27	0.41	0.12	0.24	0.46	0.33		-0.1	0.07	0.13	0.32	0.22	0.34	0.16	0.51	-0.05
Other Current Assets	0.1	-0.07	0.12	0.17	-0.13	0.14	-0.06	-0.08	-0.1	0.32	0.24	-0.04	-0.07	0.52	0.0	0.67	-0.1		-0.11	0.43	0.05	0.01	-0.47	0.16	0.27	-0.01
Other Stockholder Equity	0.04	0.14	-0.15	-0.08	-0.05	0.02	0.05	-0.03	0.55	-0.12	0.08	0.06	-0.25	0.19	-0.09	0.32	0.07	-0.11		0.11	0.1	0.12	-0.27	0.18	-0.11	0.16
Total Liab	0.83	0.41	0.52	0.87	0.29	0.55	0.45	-0.16	-0.31	-0.08	-0.01	0.46	0.63	0.72	0.48	0.29	0.13	0.43	0.11		0.84	0.59	0.13	0.77	0.7	-0.25
Total Current Assets	0.87	0.66	0.47	0.82	0.55	0.79	0.71	-0.28	-0.33	-0.39	-0.29	0.51	0.73	0.68	0.58	0.09	0.32	0.05	0.1	0.84		0.85	0.33	0.87	0.52	-0.48
Common Stock	0.68	0.61	0.26	0.66	0.53	0.82	0.65	-0.15	-0.22	-0.47	-0.48	0.41	0.64	0.53	0.48	-0.07	0.22	0.01	0.12	0.59	0.85		0.36	0.81	0.2	-0.62
Retained Earnings	0.55	0.11	0.4	0.29	0.63	0.26	0.23	-0.05	-0.63	0.2	0.04	0.22	0.63	-0.27	0.35	-0.52	0.34	-0.47	-0.27	0.13	0.33	0.36		0.03	0.43	-0.33
Short Term Debt	0.66	0.72	0.13	0.78	0.26	0.65	0.71	-0.21	-0.02	-0.51	-0.36	0.64	0.56	0.71	0.6	0.04	0.16	0.16	0.18	0.77	0.87	0.81	0.03		0.29	-0.3
Current Deferred Revenue	0.78	0.3	0.54	0.53	0.57	0.42	0.41	-0.4	-0.64	0.49	0.32	0.48	0.56	0.41	0.51	0.3	0.51	0.27	-0.11	0.7	0.52	0.2	0.43	0.29		-0.01
Other Liab	-0.35	-0.25	-0.45	-0.4	-0.44	-0.61	-0.32	0.03	0.39	0.26	0.3	0.11	-0.49	-0.33	0.04	0.11	-0.05	-0.01	0.16	-0.25	-0.48	-0.62	-0.33	-0.3	-0.01

Click cells to compare fundamentals

ITI Account Relationship Matchups

ITI fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	77.2B	89.1B	95.8B	94.9B	96.0B	63.8B
Short Long Term Debt Total	12.2B	14.6B	16.1B	18.8B	18.0B	13.9B
Other Current Liab	16.0B	29.0B	34.0B	10.0B	21.2B	15.9B
Total Current Liabilities	48.5B	59.8B	64.9B	65.9B	54.0B	51.2B
Total Stockholder Equity	23.7B	24.6B	26.2B	23.7B	17.8B	18.9B
Property Plant And Equipment Net	28.1B	28.0B	28.1B	28.2B	28.1B	29.2B
Net Debt	11.8B	14.4B	16.0B	18.7B	16.9B	13.0B
Accounts Payable	21.8B	18.9B	16.9B	13.8B	15.6B	15.0B
Cash	397.8M	279.4M	155.7M	93.6M	1.1B	602.8M
Non Current Assets Total	32.8B	32.6B	31.5B	31.2B	30.2B	31.7B
Non Currrent Assets Other	4.3B	4.2B	3.0B	2.6B	1.8B	1.7B
Cash And Short Term Investments	2.3B	4.3B	968.5M	27.9B	6.5B	4.4B
Net Receivables	40.2B	49.0B	59.2B	58.9B	24.4B	38.6B
Common Stock Shares Outstanding	897.6M	926.3M	933.5M	944.5M	959.6M	993.7M
Short Term Investments	1.9B	4.1B	812.8M	27.9B	5.5B	3.1B
Liabilities And Stockholders Equity	77.2B	89.1B	95.8B	94.9B	96.0B	63.8B
Non Current Liabilities Total	5.0B	4.7B	4.6B	5.3B	24.2B	25.4B
Inventory	1.7B	1.9B	1.9B	2.5B	2.2B	1.5B
Other Current Assets	254.2M	1.3B	2.2B	1.8B	30.8B	32.3B
Other Stockholder Equity	56.6B	25.7B	25.8B	27.1B	58.7B	36.7B
Total Liab	53.5B	64.6B	69.6B	71.2B	78.1B	61.8B
Total Current Assets	44.4B	56.5B	64.2B	63.7B	65.7B	44.2B
Accumulated Other Comprehensive Income	(1.2B)	31.6B	32.2B	31.9B	8.2B	8.6B
Common Stock	9.0B	9.3B	9.3B	9.5B	9.6B	8.0B
Retained Earnings	(43.4B)	(41.8B)	(42.1B)	(41.0B)	(50.4B)	(52.9B)
Short Term Debt	10.4B	11.7B	13.7B	17.0B	16.8B	11.3B
Current Deferred Revenue	16.1B	18.7B	20.1B	24.8B	19.7B	17.1B
Other Liab	3.2B	1.7B	1.6B	3.5B	3.1B	2.3B
Net Tangible Assets	23.2B	24.6B	26.2B	23.7B	27.3B	17.5B
Other Assets	4.3B	4.2B	5K	2K	(61.0K)	(58.0K)
Short Long Term Debt	10.4B	11.6B	13.1B	17.0B	16.8B	12.9B
Property Plant Equipment	28.1B	28.0B	28.1B	28.2B	32.5B	29.5B
Capital Surpluse	1.2B	2.2B	2.9B	4.6B	5.3B	5.5B
Non Current Liabilities Other	1.2B	1.2B	1K	(100K)	900.0	855.0
Cash And Equivalents	267.0M	397.8M	279.4M	155.7M	140.1M	234.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in ITI Stock

Balance Sheet is a snapshot of the financial position of ITI Limited at a specified time, usually calculated after every quarter, six months, or one year. ITI Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ITI and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ITI currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ITI Selling And Marketing Expenses vs Research Development Analysis

Selling And Marketing Expenses vs Research Development

Selling And Marketing Expenses vs Research Development Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Research Development

ITI fundamental ratios Correlations

ITI Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ITI fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in ITI Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 0.98	Short Long Term Debt Total
Short Term Investments	+ 0.93	Cash And Short Term Investments
Total Current Assets	+ 0.87	Total Assets
Total Liab	+ 0.87	Total Current Liabilities
Short Term Debt	+ 0.87	Total Current Assets
Net Receivables	+ 0.85	Total Current Liabilities

Inventory	- 0.85	Accounts Payable
Accounts Payable	- 0.68	Net Debt
Accounts Payable	- 0.68	Short Long Term Debt Total
Current Deferred Revenue	- 0.64	Cash
Retained Earnings	- 0.63	Cash
Other Liab	- 0.62	Common Stock